Literature DB >> 3906763

Combined modality treatment of malignant glioma.

W R Shapiro.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3906763     DOI： 10.1159/000411643

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  2 in total

1.  The potential role of lonidamine (LND) in the treatment of malignant glioma. Phase II study.

Authors:  C M Carapella; M G Paggi; F Cattani; G B Ciottoli; A Floridi; B Iandolo; L Raus; A Riccio; A Caputo
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

2.  Establishment, characterization and chemosensitivity of two human glioma derived cell lines.

Authors:  G Zupi; A Candiloro; N Laudonio; C Carapella; M Benassi; A Riccio; M Bellocci; C Greco
Journal:  J Neurooncol       Date:  1988-09       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.